Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Ally Bridge and LifeTech Form Medical Device JV with France's Quantum

publication date: Apr 4, 2019

Ally Bridge Group, a China-focused life science investor, partnered with LifeTech Scientific, a China medical device maker, and Quantum Surgical, a French surgical robotics company, to develop a surgical robot platform in China, initially aimed at liver cancer. The Quantum platform is intended to assess and treat a variety of medical conditions, with an emphasis on interventional treatment of early stage liver cancer. Previously, ABG made a Series A investment in Quantum, and it has a partnership with LifeTech. More details....

Stock Symbol: (HK: 1302)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.